Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Endoparasiticide Market Growth 2022-2028

  • LP 4831473
  • 103 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Endoparasiticide will have significant change from previous year. According to our (LP Information) latest study, the global Endoparasiticide market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Endoparasiticide market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Endoparasiticide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Endoparasiticide market, reaching US$ million by the year 2028. As for the Europe Endoparasiticide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Endoparasiticide players cover Boehringer Ingelheim, Elanco, Zoetis, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Endoparasiticide market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Ear Tags

Tablets

Injectables

Feed Additives

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Veterinary Hospitals or Clinics

Animal Farms

Home Care Settings

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Boehringer Ingelheim

Elanco

Zoetis

Merck

Virbac

Novartis AG

Ceva Sante Animlae

Bayer AG

Eli Lilly

Vetoquinol

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Endoparasiticide Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Endoparasiticide by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Endoparasiticide by Country/Region, 2017, 2022 & 2028

2.2 Endoparasiticide Segment by Type

2.2.1 Ear Tags

2.2.2 Tablets

2.2.3 Injectables

2.2.4 Feed Additives

2.3 Endoparasiticide Sales by Type

2.3.1 Global Endoparasiticide Sales Market Share by Type (2017-2022)

2.3.2 Global Endoparasiticide Revenue and Market Share by Type (2017-2022)

2.3.3 Global Endoparasiticide Sale Price by Type (2017-2022)

2.4 Endoparasiticide Segment by Application

2.4.1 Veterinary Hospitals or Clinics

2.4.2 Animal Farms

2.4.3 Home Care Settings

2.5 Endoparasiticide Sales by Application

2.5.1 Global Endoparasiticide Sale Market Share by Application (2017-2022)

2.5.2 Global Endoparasiticide Revenue and Market Share by Application (2017-2022)

2.5.3 Global Endoparasiticide Sale Price by Application (2017-2022)

3 Global Endoparasiticide by Company

3.1 Global Endoparasiticide Breakdown Data by Company

3.1.1 Global Endoparasiticide Annual Sales by Company (2020-2022)

3.1.2 Global Endoparasiticide Sales Market Share by Company (2020-2022)

3.2 Global Endoparasiticide Annual Revenue by Company (2020-2022)

3.2.1 Global Endoparasiticide Revenue by Company (2020-2022)

3.2.2 Global Endoparasiticide Revenue Market Share by Company (2020-2022)

3.3 Global Endoparasiticide Sale Price by Company

3.4 Key Manufacturers Endoparasiticide Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Endoparasiticide Product Location Distribution

3.4.2 Players Endoparasiticide Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Endoparasiticide by Geographic Region

4.1 World Historic Endoparasiticide Market Size by Geographic Region (2017-2022)

4.1.1 Global Endoparasiticide Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Endoparasiticide Annual Revenue by Geographic Region

4.2 World Historic Endoparasiticide Market Size by Country/Region (2017-2022)

4.2.1 Global Endoparasiticide Annual Sales by Country/Region (2017-2022)

4.2.2 Global Endoparasiticide Annual Revenue by Country/Region

4.3 Americas Endoparasiticide Sales Growth

4.4 APAC Endoparasiticide Sales Growth

4.5 Europe Endoparasiticide Sales Growth

4.6 Middle East & Africa Endoparasiticide Sales Growth

5 Americas

5.1 Americas Endoparasiticide Sales by Country

5.1.1 Americas Endoparasiticide Sales by Country (2017-2022)

5.1.2 Americas Endoparasiticide Revenue by Country (2017-2022)

5.2 Americas Endoparasiticide Sales by Type

5.3 Americas Endoparasiticide Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Endoparasiticide Sales by Region

6.1.1 APAC Endoparasiticide Sales by Region (2017-2022)

6.1.2 APAC Endoparasiticide Revenue by Region (2017-2022)

6.2 APAC Endoparasiticide Sales by Type

6.3 APAC Endoparasiticide Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Endoparasiticide by Country

7.1.1 Europe Endoparasiticide Sales by Country (2017-2022)

7.1.2 Europe Endoparasiticide Revenue by Country (2017-2022)

7.2 Europe Endoparasiticide Sales by Type

7.3 Europe Endoparasiticide Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Endoparasiticide by Country

8.1.1 Middle East & Africa Endoparasiticide Sales by Country (2017-2022)

8.1.2 Middle East & Africa Endoparasiticide Revenue by Country (2017-2022)

8.2 Middle East & Africa Endoparasiticide Sales by Type

8.3 Middle East & Africa Endoparasiticide Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Endoparasiticide

10.3 Manufacturing Process Analysis of Endoparasiticide

10.4 Industry Chain Structure of Endoparasiticide

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Endoparasiticide Distributors

11.3 Endoparasiticide Customer

12 World Forecast Review for Endoparasiticide by Geographic Region

12.1 Global Endoparasiticide Market Size Forecast by Region

12.1.1 Global Endoparasiticide Forecast by Region (2023-2028)

12.1.2 Global Endoparasiticide Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Endoparasiticide Forecast by Type

12.7 Global Endoparasiticide Forecast by Application

13 Key Players Analysis

13.1 Boehringer Ingelheim

13.1.1 Boehringer Ingelheim Company Information

13.1.2 Boehringer Ingelheim Endoparasiticide Product Offered

13.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Boehringer Ingelheim Main Business Overview

13.1.5 Boehringer Ingelheim Latest Developments

13.2 Elanco

13.2.1 Elanco Company Information

13.2.2 Elanco Endoparasiticide Product Offered

13.2.3 Elanco Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Elanco Main Business Overview

13.2.5 Elanco Latest Developments

13.3 Zoetis

13.3.1 Zoetis Company Information

13.3.2 Zoetis Endoparasiticide Product Offered

13.3.3 Zoetis Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Zoetis Main Business Overview

13.3.5 Zoetis Latest Developments

13.4 Merck

13.4.1 Merck Company Information

13.4.2 Merck Endoparasiticide Product Offered

13.4.3 Merck Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Main Business Overview

13.4.5 Merck Latest Developments

13.5 Virbac

13.5.1 Virbac Company Information

13.5.2 Virbac Endoparasiticide Product Offered

13.5.3 Virbac Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Virbac Main Business Overview

13.5.5 Virbac Latest Developments

13.6 Novartis AG

13.6.1 Novartis AG Company Information

13.6.2 Novartis AG Endoparasiticide Product Offered

13.6.3 Novartis AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis AG Main Business Overview

13.6.5 Novartis AG Latest Developments

13.7 Ceva Sante Animlae

13.7.1 Ceva Sante Animlae Company Information

13.7.2 Ceva Sante Animlae Endoparasiticide Product Offered

13.7.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ceva Sante Animlae Main Business Overview

13.7.5 Ceva Sante Animlae Latest Developments

13.8 Bayer AG

13.8.1 Bayer AG Company Information

13.8.2 Bayer AG Endoparasiticide Product Offered

13.8.3 Bayer AG Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bayer AG Main Business Overview

13.8.5 Bayer AG Latest Developments

13.9 Eli Lilly

13.9.1 Eli Lilly Company Information

13.9.2 Eli Lilly Endoparasiticide Product Offered

13.9.3 Eli Lilly Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eli Lilly Main Business Overview

13.9.5 Eli Lilly Latest Developments

13.10 Vetoquinol

13.10.1 Vetoquinol Company Information

13.10.2 Vetoquinol Endoparasiticide Product Offered

13.10.3 Vetoquinol Endoparasiticide Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Vetoquinol Main Business Overview

13.10.5 Vetoquinol Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Endoparasiticide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Endoparasiticide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Ear Tags

Table 4. Major Players of Tablets

Table 5. Major Players of Injectables

Table 6. Major Players of Feed Additives

Table 7. Global Endoparasiticide Sales by Type (2017-2022) & (K Units)

Table 8. Global Endoparasiticide Sales Market Share by Type (2017-2022)

Table 9. Global Endoparasiticide Revenue by Type (2017-2022) & ($ million)

Table 10. Global Endoparasiticide Revenue Market Share by Type (2017-2022)

Table 11. Global Endoparasiticide Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Endoparasiticide Sales by Application (2017-2022) & (K Units)

Table 13. Global Endoparasiticide Sales Market Share by Application (2017-2022)

Table 14. Global Endoparasiticide Revenue by Application (2017-2022)

Table 15. Global Endoparasiticide Revenue Market Share by Application (2017-2022)

Table 16. Global Endoparasiticide Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Endoparasiticide Sales by Company (2020-2022) & (K Units)

Table 18. Global Endoparasiticide Sales Market Share by Company (2020-2022)

Table 19. Global Endoparasiticide Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Endoparasiticide Revenue Market Share by Company (2020-2022)

Table 21. Global Endoparasiticide Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Endoparasiticide Producing Area Distribution and Sales Area

Table 23. Players Endoparasiticide Products Offered

Table 24. Endoparasiticide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Endoparasiticide Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Endoparasiticide Sales Market Share Geographic Region (2017-2022)

Table 29. Global Endoparasiticide Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Endoparasiticide Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Endoparasiticide Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Endoparasiticide Sales Market Share by Country/Region (2017-2022)

Table 33. Global Endoparasiticide Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Endoparasiticide Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Endoparasiticide Sales by Country (2017-2022) & (K Units)

Table 36. Americas Endoparasiticide Sales Market Share by Country (2017-2022)

Table 37. Americas Endoparasiticide Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Endoparasiticide Revenue Market Share by Country (2017-2022)

Table 39. Americas Endoparasiticide Sales by Type (2017-2022) & (K Units)

Table 40. Americas Endoparasiticide Sales Market Share by Type (2017-2022)

Table 41. Americas Endoparasiticide Sales by Application (2017-2022) & (K Units)

Table 42. Americas Endoparasiticide Sales Market Share by Application (2017-2022)

Table 43. APAC Endoparasiticide Sales by Region (2017-2022) & (K Units)

Table 44. APAC Endoparasiticide Sales Market Share by Region (2017-2022)

Table 45. APAC Endoparasiticide Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Endoparasiticide Revenue Market Share by Region (2017-2022)

Table 47. APAC Endoparasiticide Sales by Type (2017-2022) & (K Units)

Table 48. APAC Endoparasiticide Sales Market Share by Type (2017-2022)

Table 49. APAC Endoparasiticide Sales by Application (2017-2022) & (K Units)

Table 50. APAC Endoparasiticide Sales Market Share by Application (2017-2022)

Table 51. Europe Endoparasiticide Sales by Country (2017-2022) & (K Units)

Table 52. Europe Endoparasiticide Sales Market Share by Country (2017-2022)

Table 53. Europe Endoparasiticide Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Endoparasiticide Revenue Market Share by Country (2017-2022)

Table 55. Europe Endoparasiticide Sales by Type (2017-2022) & (K Units)

Table 56. Europe Endoparasiticide Sales Market Share by Type (2017-2022)

Table 57. Europe Endoparasiticide Sales by Application (2017-2022) & (K Units)

Table 58. Europe Endoparasiticide Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Endoparasiticide Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Endoparasiticide Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Endoparasiticide Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Endoparasiticide Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Endoparasiticide Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Endoparasiticide Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Endoparasiticide Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Endoparasiticide Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Endoparasiticide

Table 68. Key Market Challenges & Risks of Endoparasiticide

Table 69. Key Industry Trends of Endoparasiticide

Table 70. Endoparasiticide Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Endoparasiticide Distributors List

Table 73. Endoparasiticide Customer List

Table 74. Global Endoparasiticide Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Endoparasiticide Sales Market Forecast by Region

Table 76. Global Endoparasiticide Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Endoparasiticide Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Endoparasiticide Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Endoparasiticide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Endoparasiticide Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Endoparasiticide Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Endoparasiticide Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Endoparasiticide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Endoparasiticide Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Endoparasiticide Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Endoparasiticide Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Endoparasiticide Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Endoparasiticide Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Endoparasiticide Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Endoparasiticide Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Endoparasiticide Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Endoparasiticide Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Endoparasiticide Revenue Market Share Forecast by Application (2023-2028)

Table 94. Boehringer Ingelheim Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 95. Boehringer Ingelheim Endoparasiticide Product Offered

Table 96. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Boehringer Ingelheim Main Business

Table 98. Boehringer Ingelheim Latest Developments

Table 99. Elanco Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 100. Elanco Endoparasiticide Product Offered

Table 101. Elanco Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Elanco Main Business

Table 103. Elanco Latest Developments

Table 104. Zoetis Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 105. Zoetis Endoparasiticide Product Offered

Table 106. Zoetis Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Zoetis Main Business

Table 108. Zoetis Latest Developments

Table 109. Merck Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 110. Merck Endoparasiticide Product Offered

Table 111. Merck Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Merck Main Business

Table 113. Merck Latest Developments

Table 114. Virbac Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 115. Virbac Endoparasiticide Product Offered

Table 116. Virbac Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Virbac Main Business

Table 118. Virbac Latest Developments

Table 119. Novartis AG Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 120. Novartis AG Endoparasiticide Product Offered

Table 121. Novartis AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Novartis AG Main Business

Table 123. Novartis AG Latest Developments

Table 124. Ceva Sante Animlae Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 125. Ceva Sante Animlae Endoparasiticide Product Offered

Table 126. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Ceva Sante Animlae Main Business

Table 128. Ceva Sante Animlae Latest Developments

Table 129. Bayer AG Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 130. Bayer AG Endoparasiticide Product Offered

Table 131. Bayer AG Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Bayer AG Main Business

Table 133. Bayer AG Latest Developments

Table 134. Eli Lilly Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 135. Eli Lilly Endoparasiticide Product Offered

Table 136. Eli Lilly Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Eli Lilly Main Business

Table 138. Eli Lilly Latest Developments

Table 139. Vetoquinol Basic Information, Endoparasiticide Manufacturing Base, Sales Area and Its Competitors

Table 140. Vetoquinol Endoparasiticide Product Offered

Table 141. Vetoquinol Endoparasiticide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Vetoquinol Main Business

Table 143. Vetoquinol Latest Developments

List of Figures

Figure 1. Picture of Endoparasiticide

Figure 2. Endoparasiticide Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Endoparasiticide Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Endoparasiticide Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Endoparasiticide Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Ear Tags

Figure 10. Product Picture of Tablets

Figure 11. Product Picture of Injectables

Figure 12. Product Picture of Feed Additives

Figure 13. Global Endoparasiticide Sales Market Share by Type in 2021

Figure 14. Global Endoparasiticide Revenue Market Share by Type (2017-2022)

Figure 15. Endoparasiticide Consumed in Veterinary Hospitals or Clinics

Figure 16. Global Endoparasiticide Market: Veterinary Hospitals or Clinics (2017-2022) & (K Units)

Figure 17. Endoparasiticide Consumed in Animal Farms

Figure 18. Global Endoparasiticide Market: Animal Farms (2017-2022) & (K Units)

Figure 19. Endoparasiticide Consumed in Home Care Settings

Figure 20. Global Endoparasiticide Market: Home Care Settings (2017-2022) & (K Units)

Figure 21. Global Endoparasiticide Sales Market Share by Application (2017-2022)

Figure 22. Global Endoparasiticide Revenue Market Share by Application in 2021

Figure 23. Endoparasiticide Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Endoparasiticide Revenue Market Share by Company in 2021

Figure 25. Global Endoparasiticide Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Endoparasiticide Revenue Market Share by Geographic Region in 2021

Figure 27. Global Endoparasiticide Sales Market Share by Region (2017-2022)

Figure 28. Global Endoparasiticide Revenue Market Share by Country/Region in 2021

Figure 29. Americas Endoparasiticide Sales 2017-2022 (K Units)

Figure 30. Americas Endoparasiticide Revenue 2017-2022 ($ Millions)

Figure 31. APAC Endoparasiticide Sales 2017-2022 (K Units)

Figure 32. APAC Endoparasiticide Revenue 2017-2022 ($ Millions)

Figure 33. Europe Endoparasiticide Sales 2017-2022 (K Units)

Figure 34. Europe Endoparasiticide Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Endoparasiticide Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Endoparasiticide Revenue 2017-2022 ($ Millions)

Figure 37. Americas Endoparasiticide Sales Market Share by Country in 2021

Figure 38. Americas Endoparasiticide Revenue Market Share by Country in 2021

Figure 39. United States Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Endoparasiticide Sales Market Share by Region in 2021

Figure 44. APAC Endoparasiticide Revenue Market Share by Regions in 2021

Figure 45. China Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Endoparasiticide Sales Market Share by Country in 2021

Figure 52. Europe Endoparasiticide Revenue Market Share by Country in 2021

Figure 53. Germany Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Endoparasiticide Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Endoparasiticide Revenue Market Share by Country in 2021

Figure 60. Egypt Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Endoparasiticide Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Endoparasiticide in 2021

Figure 66. Manufacturing Process Analysis of Endoparasiticide

Figure 67. Industry Chain Structure of Endoparasiticide

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390